UNSPSC 51284143: Cefteram pivaloyloxymethyl ester

This classification denotes a cephalosporin antibiotic with the molecular formula C22H27N9O7S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0OD86RT58C, chemically known as pivaloyloxymethyl (z)-7-(2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido)-3-(5-methyl-2h-tetrazol-2-ylmethyl)-3-cephem-4-carboxylate, but more generally known as cefteram pivaloyloxymethyl ester, which bears US NIH Compound Identifier 6917871.

European Medicines Agency schedules cefteram pivaloyloxymethyl ester or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07423MIG. Most nations, for tariff purposes, schedule cefteram pivaloyloxymethyl ester under HS 29419000. SMILES: CC1NNN(N1)CC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N\OC)/C4CSC(N4)N)SC2)C(=O)OCOC(=O)C(C)(C)C.

UNSPSC 51284143 Cefteram pivaloyloxymethyl ester is a Commodity code with minimal alignment to recent state and local procurement activity in the source material. The code nominally describes a specific third-generation cephalosporin antibiotic, yet the recent opportunities posted under this code encompass naloxone and drug deactivation systems, therapeutic pharmacy initiatives, medical and first aid supplies for fire rescue, and generic multi-source pharmaceuticals and OTC products—none of which are cefteram or closely related pharmaceutical products. The code shows a clear mismatch between its narrow therapeutic scope and the broad healthcare procurement activities being tagged to it by issuing bodies.

The recent opportunities span state health commissions, county governments, and municipal fire departments across Florida, Texas, and Minnesota, with issuing bodies including Seminole County (IFB for naloxone and deactivation systems, due July 26, 2023), the Texas Health and Human Services Commission (RFI on direct-to-manufacturer prescription programs, due April 3, 2026), the City of Tampa Fire Department (IFB for medical and first aid supplies estimated at $700,000, due March 13, 2026, with SLBE set-aside and 5 percent bid discount), and the Minnesota Multistate Cooperative Purchasing Alliance (RFP for generic pharmaceuticals and OTC products, due March 26, 2026, distributed through AmerisourceBergen, Cardinal Health, and Morris & Dickson). The code does not support focused business development strategy; firms seeking opportunities in pharmaceutical procurement or emergency medical supplies should verify procurement classification before responding, as the code's actual usage diverges substantially from its defined product scope.